Embedded Medical Writing
When development portfolios expand, organizational structures shift, or internal teams reach capacity; medical writing can quickly become a bottleneck to regulatory progress.
ProPharma's FSP Medical Writing model provides dedicated, sponsor-aligned writers who integrate seamlessly into your organization, delivering continuity, scalability, and deep therapeutic expertise without increasing permanent headcount.
FSP models don't just add capacity, they create meaningful "organizational leverage". By shifting the operational management to the FSP partner, organizations significantly reduce administrative burden and unlock strategic capacity. Internal teams are no longer absorbed by managing the day-to-day execution and can instead focus on high-impact priorities such as advancing scientific strategy, shaping regulatory positions, and driving portfolio-level decisions.
Rather than outsourcing individual documents, this model delivers long-term capability: a stable team that operates within your processes, systems, and governance framework.
For project‑based deliverables, explore our Global Medical Writing & Transparency services.
Why Organizations Turn to FSP Medical Writing
Many sponsors adopt an FSP model during periods of transition, growth, or sustained volume pressure. Common drivers include:
- Acquisition or in-licensing of new compounds that strain existing resources
- Organizational restructuring that shifts ownership of programs or therapeutic areas
- Lack of specialized expertise required for complex or niche document types
- Headcount or budget constraints that prevent permanent hiring
- Sudden increases in document volume during key development phases
- Temporary staffing gaps due to extended leave or internal redeployment
- Learn more about our broader Functional Service Provider capabilities.